Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL5131 Target Snapshot

Trypanothione reductase · SINGLE PROTEIN · Trypanosoma cruzi

546Compounds
151Assays
13Approved Drugs
490.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P28593. Use UniProt P28593 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P28593 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Trypanothione reductase as ChEMBL target CHEMBL5131, mapped to UniProt P28593. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Trypanothione reductase
SINGLE PROTEIN · Trypanosoma cruzi
As of 2026-09-14
ChEMBL target ID
CHEMBL5131
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P28593
Trypanothione reductase
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Trypanothione reductase is the right protein anchor across sources, using UniProt P28593 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelTrypanothione reductase
UniProt AccessionP28593
Component TypeProtein
Sequence Length492 aa

Trypanothione reductase

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Trypanothione reductase, mapped to UniProt P28593. Sequence length is 492 aa.

Mapped IDP28593
Review nameTrypanothione reductase
OrganismTrypanosoma cruzi
Clinical Profile

Clinical Phase Distribution

13
Approved
3
Phase II
1
Phase I
Assay Mix

Activity Type Distribution

IC50303.0
KI186.0
EC501.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL76694 7.12 Ki 76.0 Preclinical
CHEMBL79129 7.12 Ki 76.0 Preclinical
CHEMBL106127 6.92 Ki 120.0 Preclinical
CHEMBL199020 6.82 Ki 150.0 Preclinical
CHEMBL85161 6.82 Ki 151.0 Preclinical
CHEMBL197230 6.75 Ki 180.0 Preclinical
CHEMBL5283195 6.7 IC50 200.0 Preclinical
CHEMBL3398189 6.59 Ki 255.0 Preclinical
CHEMBL307650 6.55 Ki 280.0 Preclinical
CHEMBL160637 6.52 IC50 300.0 Preclinical
Distribution

pChEMBL Value Distribution

73
5.0
58
5.5
28
6.0
8
6.5
2
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

175
Total Assays
316
Tested Compounds
2
Assay Types
Binding — 174 assays, 316 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 165 304 5.1
assay format 8 11 4.9
cell-based format 1 1 5.2
Functional — 1 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine